Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001891113-26-000002

Chief Business Officer sold 6,938 shares at $1.96 ($13,598)

  • Chief Business Officer acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Khan Ruhi Ahmad · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-20 Grant or award : show line 1 in the form +45,000 111,936 D
2026-02-24 Sale : show line 2 in the form −6,938 $1.96 $13,598 104,998 D
Open-market sales · 6,938 sh · avg $1.96 · $13,598

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-20 Grant or award : show line 3 in the form Option to purchase Common Stock +202,500 202,500 D
Loading xslF345X05/wk-form4_1771984441.xml…